Sponsor or institution

Clinical trials and research at AP Biosciences Inc.

As of November 12, 2026, Find a Trial lists 3 clinical trials run by AP Biosciences Inc. that are recruiting, at sites in 2 countries (most in Australia (2), Taiwan (1)). By phase: Phase 1/2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
AP601 infusions for unresectable advanced or metastatic solid tumors Phase 1 Waratah, New South Wales and 2 other locations Recruiting Sep 10, 2025
Evaluating AP402 in HER2-Positive Patients with Advanced Solid Tumors Phase 1/2 Macquarie, New South Wales and 2 other locations Recruiting Nov 1, 2024
Investigating AP203 for advanced solid tumors Phase 1/2 Taipei Recruiting Jul 25, 2022

All recruiting trials (3)

Quick answers

How many clinical trials run by AP Biosciences Inc. are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Australia (2 trials), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.